Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs Verizon Communications Inc (VZ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs Verizon Communications Inc — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.6 (market cap $30.93B), while Verizon Communications Inc trades at $44.95 (market cap $184.56B). The key difference: Verizon Communications Inc is far larger — about 6× GE HealthCare Technologies Inc. Common Stock's market cap, and Verizon Communications Inc pays the higher dividend (6.37%). Which is the better fit depends on your goals.
| GEHC | VZ | |
|---|---|---|
Market Cap | $30.93B | $184.56B |
Volume | 5,033,451 | 28,067,100 |
Sector | Health | Media |
52-Week High | $88.16 | $51.45 |
52-Week Low | $59.48 | $38.40 |
Enterprise Value | $39.39B | $371.26B |
Dividend Yield | 0.23% | 6.37% |
Typical Hold Time | — | 109 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
Verizon (VZ) trades at $43.53, up 1.75% today, with a bearish technical signal despite recent earnings beats. The stock shows attractive valuation metrics including a P/E of 11.34 and dividend yield support, while maintaining strong cash flow generation of $37.14B from operations in 2025. Recent developments include a joint satellite venture with AT&T and T-Mobile announced October 1, 2026, and upcoming Q3 earnings on October 26, 2026.
VZ presents a value opportunity with solid fundamentals but faces technical headwinds. The company's consistent dividend payments and improving cash flow trends provide income stability, while competitive pressures in the telecom sector and high debt levels ($144B total debt) represent ongoing challenges. Analyst consensus targets $47.83 with 38% buy ratings, suggesting moderate upside potential from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About Verizon Communications Inc
Verizon Communications Inc. is an integrated telecommunications company that provides wire line voice and data services, wireless services, Internet services, and published directory information. The Company also provides network services for the federal government including business phone lines, data services, telecommunications equipment, and payphones.
Read more on VZ →
